Email Newsletters

News

Baker talks jobs, MBTA

Speaking at a business breakfast Thursday morning, Gov. Charlie Baker waxed nostalgic about the effort to woo General Electric to Boston and informed the room that some of the MBTA's equipment dates back to the Taft administration.

Insulin treatment developed in Shrewsbury shows strong results

The V-Go insulin treatment developed by Valeritas Inc. performed well in the latest study published in the official peer-reviewed journal of the American Association of Clinical Endocrinologists (AACE).

Marlborough co. ranks ‘coziest’ U.S. cities

The maker of Honeywell portable heaters has released its list of coziest cities in the United States, with Asheville, N.C. just edging out Boston to take the top honor.

BAA buys Boston Marathon start line home for $1.2M

The Boston Athletic Association has paid $1.2 million for a home near the start of the Boston Marathon Start line in Hopkinton.
ADVERTISEMENT

Worcester ECHL hockey team vote set for Friday

Confirmation of a new Worcester hockey team seems likely as the ECHL's Board of Governors prepares to meet Friday to discuss a new franchise set to play at the DCU Center.

Fallon expands elderly health care program

Fallon Health of Worcester has opened its sixth Summit ElderCare services branch.

Incorporations

These Central Massachusetts businesses filed incorporation papers with the Massachusetts Secretary of State's Office from Nov. 14-30....

Hologic reports strong first quarter; income up 190 percent

Marlborough-based Hologic reported a strong start to the year, with 12.8 percent growth in U.S. sales of its testing and diagnostic equipment.
ADVERTISEMENT

Healey: Hep C drug pricing might be ‘unfair trade practice’

Referencing a relatively new hepatitis C drug that costs $84,000 for a full course of treatment, Attorney General Maura Healey on Wednesday used an address before members of the biotechnology industry to call for greater transparency in drug pricing and prices that make health care accessible to those who need it.

Sunovion drug passes abuse liability study

A new drug in late-stage development by Marlborough's Sunovion Pharmaceuticals Inc. has cleared a test to evaluate its potential abuse by patients.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA